Cannabis Testing Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Global Cannabis Testing Services Market is Segmented by Product and Software/Service (Analytical Instruments, Spectroscopy Instruments, Consumables, and Cannabis Testing Software and Services), Type (Potency Testing, Terpene Profiling, Residual Solvent Screening, Heavy Metal Testing, Mycotoxin Testing, and Other Types), End User (Laboratories, Cannabis Drug Manufacturers and Dispensaries, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The Report Offers the Value (in USD Million) for the Above Segments.

Cannabis Testing Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Cannabis Testing Market Size

Global Cannabis Testing Market (2025 - 2030)
Study Period 2019 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 1.26 Billion
Market Size (2030) USD 2.33 Billion
CAGR (2025 - 2030) 13.12 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Cannabis Testing Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Cannabis Testing Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Cannabis Testing Market Analysis

The Global Cannabis Testing Market size is estimated at USD 1.26 billion in 2025, and is expected to reach USD 2.33 billion by 2030, at a CAGR of 13.12% during the forecast period (2025-2030).

The impact of COVID-19 on this industry is still being studied. On one hand, due to the shutdown of non-essential labs and testing facilities across the world in response to COVID-19-induced lockdowns, sales of cannabis testing equipment and services were a bit low. However, there has been positive news too. In April 2020, two Israel-based companies, Eybna and CannaSoul, collaborated to work on a patented cannabis terpene formulation for treating COVID-19. The companies are examining the efficacy of the cannabis terpene formulation, which is being used to treat a diverse range of inflammatory conditions, including the cytokine storm syndrome caused by COVID-19. Collaborations and increased research in this segment are likely to create demand for cannabis testing services to isolate novel compounds.

The major factor attributing to the growth of the market is the increasing approval for the use of medical cannabis. The legal usage of cannabis for medical purposes is steadily growing but varies across countries based on the possession, distribution, cultivation, and medical indications for its consumption. In addition, there is an increasing volume of research supporting the use of marijuana for medical purposes, while some studies demonstrated it to be a potential means of fighting the opioid epidemic. Government bodies of several countries across North America, Europe, and South America have legalized the use of medicinal marijuana completely or for limited usage in certain forms on a strict basis. Globally, there are about 40 countries that allow the legal use of marijuana that is distributed through prescription or limited use in ayurvedic medicines. The use of hemp-based products has seen favorable legislation since the passage of the United States Farm Bill in 2018. The bill allowed the broad-based cultivation of hemp while restricting it to pilot programs for studying market interest in hemp-derived products. The bill explicitly allowed the transfer of hemp-derived products across state lines for commercial or other purposes. Additionally, it puts no restrictions on the sale, transport, or possession of hemp-derived products, so long as those items are produced in a manner consistent with the law. In February 2021, lawmakers in the United States stated that they were planning new legislation that would end the federal prohibition on marijuana, which has been legalized to some degree by many states. These initiatives are likely to impact the demand for cannabis testing equipment in a positive manner. As cannabis-based products find increased legislation and come under the ambit of law, the demand for testing equipment is expected to increase during the study period.

Cannabis extracts are also used to treat many neurological and mental disorders. As the incidence of these disorders increases, along with the increase in use and production of cannabis, the cannabis testing market is also expected to grow during the forecast period. According to the European Brain Council, as of 2022, approximately 600 neurological disorders reported around the world, placing mental disorders among the leading causes of ill-health and disability globally. Depression is the most common mental disorder. Globally, more than 264 million people of all ages suffer from depression. More women are affected by depression than men. Furthermore, growing awareness and adoption of software services in labs testing cannabis are other factors boosting the market.

The recent initiatives in cannabis testing by various key market players are likely to add to the market growth. For instance, in September 2022, Method Testing Labs, a third-party cannabis and hemp testing facility launched in 2021, opened a Florida-based lab located in Brandon, Florida. Such activities are expected to add to the market growth.

However, the high cost involved in cannabis testing instruments is a major drawback of the market growth.

Cannabis Testing Industry Overview

The cannabis testing market is moderately consolidated and consists of some major players. Some of the companies currently dominating the market are Agilent Technologies Inc., Shimadzu Scientific Instruments, Merck KGaA, Restek Corporation, PerkinElmer Inc., Danaher Corporation, Accelerated Technology Laboratories Inc., Steep Hill Halent Laboratories Inc., Digipath Inc., and Pharmlabs LLC.

Cannabis Testing Market Leaders

  1. Shimadzu Scientific Instruments.

  2. Merck KGaA (Sigma Aldrich)

  3. Restek Corporation

  4. PerkinElmer Inc.

  5. Agilent Technologies, Inc

  6. *Disclaimer: Major Players sorted in no particular order
Cannabis Testing Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Cannabis Testing Market News

  • August 2022: Florida-based cannabis testing company ACS Laboratory launched its own national hemp compliance testing panel. The panel aids in testing hemp samples for 18 cannabinoids, 105 pesticides, 24 heavy metals, 55 potential residual solvents, 17 different microorganisms, and every required mycotoxin to detect parts per billion, as well as for moisture content, water activity, and terpenes.
  • July 2022: Green Scientific Labs launched new tech for the cannabis testing process. The custom-designed software was built for the cannabis industry.

Cannabis Testing Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Legalization of Cannabis for Various Medical Purposes
    • 4.2.2 Increasing Awareness regarding Cannabis for Treating Neurological Diseases
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Analytical Instruments
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - in USD Millions)

  • 5.1 By Product and Software/Service
    • 5.1.1 Analytical Instruments
    • 5.1.2 Spectroscopy Instruments
    • 5.1.3 Consumables
    • 5.1.4 Cannabis Testing Software and Services
  • 5.2 By Type
    • 5.2.1 Potency Testing
    • 5.2.2 Terpene Profiling
    • 5.2.3 Residual Solvent Screening
    • 5.2.4 Heavy Metal Testing
    • 5.2.5 Mycotoxin Testing
    • 5.2.6 Other Types
  • 5.3 By End User
    • 5.3.1 Laboratories
    • 5.3.2 Cannabis Drug Manufacturers and Dispensaries
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies Inc.
    • 6.1.2 Shimadzu Scientific Instruments
    • 6.1.3 Merck KGaA (Sigma Aldrich)
    • 6.1.4 Restek Corporation
    • 6.1.5 PerkinElmer Inc.
    • 6.1.6 Danaher Corporation
    • 6.1.7 Accelerated Technology Laboratories Inc.
    • 6.1.8 Steep Hill Halent Laboratories Inc.
    • 6.1.9 Digipath Inc.
    • 6.1.10 Pharmlabs LLC
    • 6.1.11 Sartorius AG
    • 6.1.12 AB Sciex Pte. Ltd
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Cannabis Testing Industry Segmentation

As per the scope of the report, cannabis is proven to be effective in various medical applications, such as reducing nausea caused due to chemotherapy, stimulating appetite in AIDS patients, controlling muscular spasms in multiple sclerosis patients, etc. Cannabis testing refers to the analytical examination of cannabis to ensure its safety before human consumption. The Cannabis Testing Market is Segmented by Product and Software/Service (Analytical Instruments, Spectroscopy Instruments, Consumables, and Cannabis Testing Software and Services), Type (Potency Testing, Terpene Profiling, Residual Solvent Screening, Heavy Metal Testing, Mycotoxin Testing, and Other Types), End User (Laboratories, Cannabis Drug Manufacturers and Dispensaries, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The Market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product and Software/Service Analytical Instruments
Spectroscopy Instruments
Consumables
Cannabis Testing Software and Services
By Type Potency Testing
Terpene Profiling
Residual Solvent Screening
Heavy Metal Testing
Mycotoxin Testing
Other Types
By End User Laboratories
Cannabis Drug Manufacturers and Dispensaries
Other End Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Cannabis Testing Market Research FAQs

How big is the Global Cannabis Testing Market?

The Global Cannabis Testing Market size is expected to reach USD 1.26 billion in 2025 and grow at a CAGR of 13.12% to reach USD 2.33 billion by 2030.

What is the current Global Cannabis Testing Market size?

In 2025, the Global Cannabis Testing Market size is expected to reach USD 1.26 billion.

Who are the key players in Global Cannabis Testing Market?

Shimadzu Scientific Instruments., Merck KGaA (Sigma Aldrich), Restek Corporation, PerkinElmer Inc. and Agilent Technologies, Inc are the major companies operating in the Global Cannabis Testing Market.

Which is the fastest growing region in Global Cannabis Testing Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Cannabis Testing Market?

In 2025, the North America accounts for the largest market share in Global Cannabis Testing Market.

What years does this Global Cannabis Testing Market cover, and what was the market size in 2024?

In 2024, the Global Cannabis Testing Market size was estimated at USD 1.09 billion. The report covers the Global Cannabis Testing Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Cannabis Testing Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Cannabis Testing Industry Report

Statistics for the 2025 Global Cannabis Testing market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Cannabis Testing analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Cannabis Testing Market Report Snapshots